Joint workshop by ILGA-Europe and EATG on HIV

16/02

On 9-10 February 2017 ILGA-Europe and EATG jointly implemented a capacity building seminar on the role of LGBTI organisations to…

News from CROI2017? Here is your coverage

15/02

If you want to follow the news from the Conference on Retroviruses and Opportunistic Infections CROI currently held in Seattle,…

Video reports from the HepHIV conference and the ECDC symposium in Malta

13/02

The HIV and HCV testing and surveillance symposium organised by the Maltese Presidency of the EU and ECDC, and the…

How to keep HIV cure-related trials ethical: the benefit/risk ratio challenge

21/02

Re: Special Issue of the Journal of Medical Ethics on the ethics and challenges of an HIV cure For most…

WHO guidelines on hepatitis B and C testing

21/02

Overview Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention…

New nano approach could cut dose of leading HIV treatment in half

21/02

Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been…

Access to highly effective hepatitis C treatment in Portugal – A Community Perspective

16/12

EATG is pleased to share this new resource: Access to highly effective hepatitis C treatment in Portugal - A Community…

The European AIDS Treatment News (EATN) complete collection 1992 – 2001 is now available

03/08

The EATG published the European AIDS Treatment News (EATN) for 10 years. This “newsletter” disseminated information for expert patients and treatment activists…

Beyond viral suppression of HIV – the new quality of life frontier

23/06

Co authored by Luís Mendão and Nikos Dedes, both members of the Board of Directors, this article in BMC Medicine discusses…

Joint workshop by ILGA-Europe and EATG on HIV

16/02

On 9-10 February 2017 ILGA-Europe and EATG jointly implemented a capacity building seminar on the role of LGBTI organisations to…

News from CROI2017? Here is your coverage

15/02

If you want to follow the news from the Conference on Retroviruses and Opportunistic Infections CROI currently held in Seattle,…

Video reports from the HepHIV conference and the ECDC symposium in Malta

13/02

The HIV and HCV testing and surveillance symposium organised by the Maltese Presidency of the EU and ECDC, and the…

How to keep HIV cure-related trials ethical: the benefit/risk ratio challenge

21/02

Re: Special Issue of the Journal of Medical Ethics on the ethics and challenges of an HIV cure For most…

WHO guidelines on hepatitis B and C testing

21/02

Overview Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention…

New nano approach could cut dose of leading HIV treatment in half

21/02

Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been…

Access to highly effective hepatitis C treatment in Portugal – A Community Perspective

16/12

EATG is pleased to share this new resource: Access to highly effective hepatitis C treatment in Portugal - A Community…

The European AIDS Treatment News (EATN) complete collection 1992 – 2001 is now available

03/08

The EATG published the European AIDS Treatment News (EATN) for 10 years. This “newsletter” disseminated information for expert patients and treatment activists…

Beyond viral suppression of HIV – the new quality of life frontier

23/06

Co authored by Luís Mendão and Nikos Dedes, both members of the Board of Directors, this article in BMC Medicine discusses…